Peter Sandner

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 10

Top Topics

Chronic Kidney Disease

Duchenne Muscular Dystrophy

Top Venues

British journal of pharmacology

International journal of molecular sciences

The Journal of pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Jan R Kraehling, Agnes Benardeau, Tibor Schomber, Laura Popp, Julia Vienenkoetter, Heidrun Ellinger-Ziegelbauer, Mira Pavkovic, Elke Hartmann, Krystyna Siudak, Alexius Freyberger, Ina Hagelschuer, Ilka Mathar, Joerg Hueser, Michael G Hahn, Volker Geiss, Frank Eitner, Peter Sandner
The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 Rats. International journal of molecular sciences 24 (17) (2023)
Frank Wunder, Johannes-Peter Stasch, Andreas Knorr, Thomas Mondritzki, Damian Brockschnieder, Eva-Maria Becker-Pelster, Peter Sandner, Hanna Tinel, Gorden Redlich, Ingo V Hartung, Alexandros Vakalopoulos, Markus Follmann
Identification and characterization of the new generation sGC stimulator BAY 1165747 (BAY-747) designed for the treatment of resistant hypertension. British journal of pharmacology (2023)
Irina V Zabbarova, Youko Ikeda, Mark G Kozlowski, Pradeep Tyagi, Lori Ann Birder, Basu Chakrabarty, Subashan Kpg Perera, Rajiv Dhir, Adam C Straub, Peter Sandner, Karl-Erik Andersson, Marcus J Drake, Christopher Henry Fry, Anthony J Kanai
Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator. The Journal of pathology 256 (4) (2022)
Carina Mauersberger, Hendrik B Sager, Jana Wobst, Tan An Dang, Laura Lambrecht, Simon Koplev, Marlène Stroth, Noomen Bettaga, Jens Schlossmann, Frank Wunder, Andreas Friebe, Johan L M Björkegren, Lisa Dietz, Sanne L Maas, Emiel P.C. van der Vorst, Peter Sandner, Oliver Soehnlein, Heribert Schunkert, Thorsten Kessler
Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation. Nature cardiovascular research 1 (12) (2022)
Shalini Murali Krishnan, Johannes Nordlohne, Lisa Dietz, Alexandros Vakalopoulos, Petra Haning, Elke Hartmann, Roland Seifert, Jörg Hüser, Ilka Mathar, Peter Sandner
Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy. International journal of molecular sciences 22 (15) (2021)
Agnès Bénardeau, Antje Kahnert, Tibor Schomber, Jutta Meyer, Mira Pavkovic, Axel Kretschmer, Bettina Lawrenz, Elke Hartmann, Ilka Mathar, Joerg Hueser, Jan R Kraehling, Frank Eitner, Michael G Hahn, Johannes-Peter Stasch, Peter Sandner
Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease. Naunyn-Schmiedeberg's archives of pharmacology 394 (12) (2021)
Katharina Boden, Peter Sandner, Lothar Roessig, Julia Vogel, Julio Alonso Chirinos, Thomas Mondritzki
Vericiguat Improves Aortic Wave Reflection Parameters in a New Preclinical Model of Hypertension. Circulation. Heart failure (2021)
Daniel Stehle, Min Ze Xu, Tibor Schomber, Michael G Hahn, Frank Schweda, Susanne Feil, Jan R Kraehling, Frank Eitner, Andreas Patzak, Peter Sandner, Robert Feil, Agnès Bénardeau
Novel soluble guanylyl cyclase activators increase glomerular cGMP, induce vasodilation and improve blood flow in the murine kidney. British journal of pharmacology (2021)
Ellis Nelissen, Elentina K Argyrousi, Nick P Van Goethem, Fuqiang Zhao, Catherine D G Hines, Gayathri Swaminath, Michael Gerisch, Joerg Hueser, Peter Sandner, Jos Prickaerts
Soluble Guanylate Cyclase Stimulator Vericiguat Enhances Long-Term Memory in Rats without Altering Cerebral Blood Volume. Biomedicines 9 (8) (2021)
Peter Sandner, Markus Follmann, Eva Becker-Pelster, Michael G Hahn, Christian Meier, Cecilia Freitas, Lothar Roessig, Johannes-Peter Stasch
Soluble GC stimulators and activators: Past, present and future. British journal of pharmacology (2021)